Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
January 14, 2005
Improved brain uptake and pharmacological activity profile of morphine-6-glucuronide using a peptide vector-mediated strategy
Jamal Temsamani, Cécile Bonnafous, Christophe Rousselle, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 19, 2003
Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy
Christophe Rousselle, Philippe Clair, Maria Smirnova, et al.
Toxics
|
January 20, 2023
Partitioning of Persistent Organic Pollutants between Adipose Tissue and Serum in Human Studies
Meg-Anne Moriceau, German Cano-Sancho, MinJi Kim, et al.
Journal of Hazardous Materials
|
December 21, 2018
Fireproofing of domestic upholstered furniture: Migration of flame retardants and potential risks
Mohammed Lounis, Stéphane Leconte, Christophe Rousselle, et al.
Regulatory Toxicology and Pharmacology : RTP
|
February 24, 2023
Proposal for reference values for the developmental effects of valproate based on human data using a benchmark dose approach
Isabelle Manière-Guerrero, Erminio Bonizzoni, Dina Battino, et al.
Archives of Neurology
|
December 15, 2004
Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia
Alexandra Dürr, Agnès Camuzat, Emilie Colin, et al.
International Journal of Hygiene and Environmental Health
|
June 5, 2021
Chemical prioritisation strategy in the European Human Biomonitoring Initiative (HBM4EU) - Development and results
Eva Ougier, Catherine Ganzleben, Pierre Lecoq, et al.
NAM Journal
|
June 29, 2026
Corrigendum to "Scientific Opinion on Biphenyl-2-ol and Sodium 2-biphenylolate used in cosmetic products (CAS/EC No. 90-43-7/201-993-5 and 132-27-4/205-055-6)- SCCS/1669/24" [NAM Journal Volume 1, 2025, 100035]
Ulrike Bernauer, Laurent Bodin, Qasim Chaudhry, et al.
Journal of Medicinal Chemistry
|
November 30, 2004
Structure-activity relationships in platelet-activating factor. 12. Synthesis and biological evaluation of platelet-activating factor antagonists with anti-HIV-1 activity
Nawal Serradji, Marc Martin, Okkacha Bensaid, et al.
Regulatory Toxicology and Pharmacology : RTP
|
September 24, 2021
The SCCS scientific advice on the safety of nanomaterials in cosmetics
, Ulrike Bernauer, Laurent Bodin, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
The Journal of Pharmacology and Experimental Therapeutics
|
January 14, 2005
Improved brain uptake and pharmacological activity profile of morphine-6-glucuronide using a peptide vector-mediated strategy
Jamal Temsamani, Cécile Bonnafous, Christophe Rousselle, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 19, 2003
Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy
Christophe Rousselle, Philippe Clair, Maria Smirnova, et al.
Toxics
|
January 20, 2023
Partitioning of Persistent Organic Pollutants between Adipose Tissue and Serum in Human Studies
Meg-Anne Moriceau, German Cano-Sancho, MinJi Kim, et al.
Journal of Hazardous Materials
|
December 21, 2018
Fireproofing of domestic upholstered furniture: Migration of flame retardants and potential risks
Mohammed Lounis, Stéphane Leconte, Christophe Rousselle, et al.
Regulatory Toxicology and Pharmacology : RTP
|
February 24, 2023
Proposal for reference values for the developmental effects of valproate based on human data using a benchmark dose approach
Isabelle Manière-Guerrero, Erminio Bonizzoni, Dina Battino, et al.
Archives of Neurology
|
December 15, 2004
Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia
Alexandra Dürr, Agnès Camuzat, Emilie Colin, et al.
International Journal of Hygiene and Environmental Health
|
June 5, 2021
Chemical prioritisation strategy in the European Human Biomonitoring Initiative (HBM4EU) - Development and results
Eva Ougier, Catherine Ganzleben, Pierre Lecoq, et al.
NAM Journal
|
June 29, 2026
Corrigendum to "Scientific Opinion on Biphenyl-2-ol and Sodium 2-biphenylolate used in cosmetic products (CAS/EC No. 90-43-7/201-993-5 and 132-27-4/205-055-6)- SCCS/1669/24" [NAM Journal Volume 1, 2025, 100035]
Ulrike Bernauer, Laurent Bodin, Qasim Chaudhry, et al.
Journal of Medicinal Chemistry
|
November 30, 2004
Structure-activity relationships in platelet-activating factor. 12. Synthesis and biological evaluation of platelet-activating factor antagonists with anti-HIV-1 activity
Nawal Serradji, Marc Martin, Okkacha Bensaid, et al.
Regulatory Toxicology and Pharmacology : RTP
|
September 24, 2021
The SCCS scientific advice on the safety of nanomaterials in cosmetics
, Ulrike Bernauer, Laurent Bodin, et al.
Page
of 7